Du, Y., Li, K., Liu, W., Song, R., Luo, M., He, J., . . . Qu, X. (2022). Recent Advances in Neuromyelitis Optica Spectrum Disorder: Pathogenesis, Mechanisms and Potential Treatments. Current pharmaceutical design, 28(4), 272. https://doi.org/10.2174/1381612827666210329101335
Chicago-Zitierstil (17. Ausg.)Du, Yi, Kaijun Li, Wei Liu, Ruitong Song, Meifeng Luo, Jianfeng He, Xiaoyu Xu, und Xiaosheng Qu. "Recent Advances in Neuromyelitis Optica Spectrum Disorder: Pathogenesis, Mechanisms and Potential Treatments." Current Pharmaceutical Design 28, no. 4 (2022): 272. https://doi.org/10.2174/1381612827666210329101335.
MLA-Zitierstil (9. Ausg.)Du, Yi, et al. "Recent Advances in Neuromyelitis Optica Spectrum Disorder: Pathogenesis, Mechanisms and Potential Treatments." Current Pharmaceutical Design, vol. 28, no. 4, 2022, p. 272, https://doi.org/10.2174/1381612827666210329101335.